Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
04/1996
04/04/1996WO1996010040A1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
04/04/1996WO1996010037A1 Peptide inhibitors of farnesyl-protein transferase
04/04/1996WO1996010036A1 A process for the quantitative synthesis of 3-(l-pyroglutamyl)-l-thiazolidine-4-carboxylic acid and derivatives thereof
04/04/1996WO1996010035A1 Inhibitors of farnesyl-protein transferase
04/04/1996WO1996010034A2 Thiol-free inhibitors of farnesyl-protein transferase
04/04/1996WO1996010014A1 Aldehyde derivatives as upsteine protease inhibitors
04/04/1996WO1996010011A1 Inhibitors of farnesyl-protein transferase
04/04/1996WO1996009837A1 Muramyl peptide compositions for inhibiting hiv replication
04/04/1996WO1996009836A1 Inhibitors of farnesyl-protein transferase
04/04/1996WO1996009821A1 Inhibitors of farnesyl-protein transferase
04/04/1996DE4433572A1 New metal complexes of cyclic peptide(s), esp. with aspartic acid units
04/04/1996DE4433564A1 New metal complexes of linear peptide(s)
04/04/1996CA2201351A1 Inhibitors of farnesyl-protein transferase
04/04/1996CA2201350A1 Inhibitors of farnesyl-protein transferase
04/04/1996CA2201349A1 Inhibitors of farnesyl-protein transferase
04/04/1996CA2201348A1 Thiol-free inhibitors of farnesyl-protein transferase
04/04/1996CA2201346A1 Inhibitors of farnesyl-protein transferase
04/04/1996CA2201122A1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
04/04/1996CA2200993A1 Compositions of muramyl peptides inhibiting the replication of hiv
04/04/1996CA2196182A1 Aldehyde derivatives as upsteine protease inhibitors
04/03/1996EP0704440A1 A method of preparing N-formyl-L-aspartic anhydride
04/02/1996US5504191 Human cancer inhibitory pentapeptide methyl esters
04/02/1996US5504189 Peptides, their preparation and use
04/02/1996US5504115 Inhibitors of farnesyl protein transferase
04/02/1996US5504080 Benzo-fused lactams
04/02/1996US5504071 Compounds with a sequence of three radicals, the central one being α-a
04/02/1996US5504070 Inhibitors of the conversion of big endothelin to endothelin
04/02/1996US5503776 Protective coatings, emulsifiers, bactericides, ultraviolet absorbers, chelating
03/1996
03/29/1996CA2159261A1 Method of preparing n-formyl-l-aspartic anhydride
03/28/1996WO1996009316A1 Parallel selex
03/28/1996DE4434288A1 Substd. heterocyclic carboxylic acid amides and their prepn.
03/28/1996DE4433928A1 Substd. heterocyclic carboxylic acid amides and their prepn.
03/27/1996EP0703222A1 3-aminoazepine compound and pharmaceutical use thereof
03/27/1996EP0702696A1 Trifunctional antithrombin and antiplatelet peptides
03/27/1996EP0702674A1 Compound for protective and anchor groups and its use
03/27/1996EP0702570A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION
03/26/1996US5502238 Neutralization, homogenizing, supersaturation, aqueous solutions
03/26/1996US5502165 Process for peptide segment condensation
03/26/1996US5502061 Peptidyl substituted benzamides and naphthamies
03/26/1996US5502036 Viricides
03/26/1996US5502033 Antimicrobial polypeptide compound a pharmaceutical composition comprising the same, and a method for treating infectious diseases
03/26/1996US5502032 Peptides, the preparation and use thereof
03/26/1996US5501797 Process for recovery of raw materials in the aspartame preparation process
03/26/1996US5501712 Method for crystallization of α-L-aspartyl-L-phenylalanine methyl ester
03/21/1996WO1996008513A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same
03/21/1996WO1996008264A1 Synthetic antibiotics
03/21/1996WO1996006108A3 Cyclic cs-1 peptidomimetics, compositions and methods of using the same
03/20/1996EP0701818A2 Therapeutic methods using catalytic antibodies
03/20/1996EP0701568A1 New peptide derivatives
03/20/1996EP0701567A1 New peptides derivatives
03/20/1996EP0701446A1 Hemoregulatory peptides
03/20/1996CN1119019A Compositions and methods for the treatment of immunomediated inflammatory disorders
03/20/1996CN1031344C Process for preparing peptides inhibiting maturation of T-lymphocytes and activity of macrophages
03/19/1996US5500414 Derivatives of peptides usable as inhibitors of bacterial collagenases
03/19/1996US5500208 Oral compositions comprising a novel tripeptide
03/14/1996WO1996007672A2 Protective and linking groups and their use (carbamides)
03/14/1996WO1996007671A1 Racemization-free preparation of n-amino acid derivatives and dipeptides
03/14/1996WO1996007629A1 Technetium chelates to be used for determining the renal function
03/14/1996CA2198898A1 Protective or anchor groups and their use
03/13/1996EP0700928A1 Nucleic acid-binding oligomers for therapy and diagnostics
03/13/1996EP0700927A1 A method of preparing L-aspartyl-D-alpha-aminoalkanecarboxylic acid-(S)-N-alpha-alkylbenzylamide
03/13/1996EP0700302A1 Method of treating diabetes mellitus
03/13/1996EP0700287A1 Arylating medicaments
03/13/1996EP0690841A4 Synthetic matrix metalloprotease inhibitors and uses thereof
03/13/1996EP0502926B1 Anti-thrombotic peptides and pseudopeptides
03/13/1996EP0436545B1 Therapeutic methods using catalytic antibodies
03/13/1996CN1118601A Inhibitors of herpes viral ribonucleotide reductase
03/13/1996CN1031267C Compounds for anti-dementia medicine and its usage
03/12/1996US5498779 Anticoagulants and treatment of asthma
03/12/1996US5498728 Osteoporosis
03/12/1996US5498695 Tripeptide derivatives for gastrointestinal disorders, enzyme inhibitors and nonsteroid antiinflammatory drugs
03/12/1996CA1338163C Process for the preparation of n-alkylated dipeptides and their esters
03/12/1996CA1338162C Process for the preparation of n-alkylated dipeptides and their esters
03/08/1996CA2157639A1 Method of preparing l-aspartyl-d-.alpha.-aminoalkanecarboxylic acid-(s)-n-.alpha.-alkylbenzylamide
03/07/1996WO1996006855A1 NEW PEPTIDE DERIVATIVES WITH δ OPIOID RECEPTOR ANTAGONIST OR MIXED ν AGONIST/δ ANTAGONIST EFFECTS
03/07/1996DE4431513A1 Racemisierungsfreie Herstellung und Verwendung von N-Methoxy- oder -Hydroxy-benzyl-Aminosäurederivaten und -Dipeptiden Racemization preparation and use of N-methoxy-benzyl or hydroxy-protected dipeptides and amino acid derivatives
03/07/1996DE4431317A1 Schutz- bzw. Ankergruppen und deren Verwendung Protective or anchor groups and their use
03/07/1996CA2197566A1 New peptide derivatives with .delta. opioid receptor antagonist or mixed.mu. agonist/.delta. antagonist effects
03/06/1996EP0699208A1 Novel peptide nucleic acids
03/06/1996EP0699074A1 Thrombin inhibitors
03/05/1996US5496938 Nucleic acid ligands to HIV-RT and HIV-1 rev
03/05/1996US5496928 Endothelin antagonistic substance
03/05/1996US5496927 Peptidase inhibitors
03/05/1996US5496856 Aspartame for its application as a therapeutically active substance
03/05/1996US5496834 Peptide derivatives as cathepsin l inhibitors and inhibitors of bone resorption or treatment of osteoporosis
03/05/1996US5496710 Modified neutral metallo-protease having specified amino acid sequence
03/05/1996CA1338121C Anticonvulsant and neuroprotective 2-aminoacetamide derivatives
02/1996
02/29/1996WO1996006185A1 Assay for the detection of proteases
02/29/1996WO1996006108A2 Cyclic cs-1 peptidomimetics, compositions and methods of using the same
02/29/1996CA2198352A1 Assay for the detection of proteases
02/28/1996EP0698015A1 Preparation of n-cyanodithioimino-carbonates and 3-mercapto-5-amino-1h-1,2,4-triazole
02/28/1996EP0697884A1 Ligand precursors for incorporation into peptides
02/28/1996EP0697882A1 Use of glutathione diesters
02/28/1996EP0659184B1 Optically active hydroquinine (amino-3 phenyl)-1 ethanesulfonate, preparation and use thereof
02/28/1996CN1117492A Treatment of H. pylori infections
02/27/1996US5495047 Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy
02/27/1996US5494919 2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
02/27/1996US5494898 Peptide skeletal muscle relaxants
02/27/1996US5494897 Pentapeptides, linear or cyclic
02/27/1996US5494806 A genetic engineered, hybridized probe consisting of an 18-polynucleotides sequence
1 ... 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 ... 307